<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">56427</article-id><article-id pub-id-type="doi">10.7554/eLife.56427</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Chemical and structural investigation of the paroxetine-human serotonin transporter complex</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-177959"><name><surname>Coleman</surname><given-names>Jonathan A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177960"><name><surname>Navratna</surname><given-names>Vikas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177961"><name><surname>Antermite</surname><given-names>Daniele</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177962"><name><surname>Yang</surname><given-names>Dongxue</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177963"><name><surname>Bull</surname><given-names>James A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3993-5818</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-5270"><name><surname>Gouaux</surname><given-names>Eric</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8549-2360</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Vollum Institute</institution>, <institution>Oregon Health and Science University</institution>, <addr-line><named-content content-type="city">Portland</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Chemistry</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5893"><name><surname>Forrest</surname><given-names>Lucy R</given-names></name><role>Reviewing editor</role><aff><institution>National Institute of Neurological Disorders and Stroke, National Institutes of Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>gouauxe@ohsu.edu</email> (EG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>07</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e56427</elocation-id><history><date date-type="received"><day>27</day><month>02</month><year>2020</year></date><date date-type="accepted"><day>02</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Coleman et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Coleman et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-56427-v1.pdf"/><abstract><p>Antidepressants target the serotonin transporter (SERT) by inhibiting serotonin reuptake. Structural and biochemical studies aiming to understand binding of small-molecules to conformationally dynamic transporters like SERT often require thermostabilizing mutations and antibodies to stabilize a specific conformation, leading to questions about relationships of these structures to the bonafide conformation and inhibitor binding poses of wild-type transporter. To address these concerns, we determined the structures of ∆N72/∆C13 and ts2-inactive SERT bound to paroxetine analogues using single-particle cryo-EM and x-ray crystallography, respectively. We synthesized enantiopure analogues of paroxetine containing either bromine or iodine instead of fluorine. We exploited the anomalous scattering of bromine and iodine to define the pose of these inhibitors and investigated inhibitor binding to Asn177 mutants of ts2-active SERT. These studies provide mutually consistent insights into how paroxetine and its analogues bind to the central substrate-binding site of SERT, stabilize the outward-open conformation, and inhibit serotonin transport.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>5R37MH070039</award-id><principal-award-recipient><name><surname>Gouaux</surname><given-names>Eric</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Gouaux</surname><given-names>Eric</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>UF140161</award-id><principal-award-recipient><name><surname>Bull</surname><given-names>James A</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>RG150444</award-id><principal-award-recipient><name><surname>Bull</surname><given-names>James A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The coordinates and associated volumes for the cryo-EM reconstruction of SERT 8B6 Fab paroxetine, Br-paroxetine, and I-paroxetine datasets have been deposited in the PDB (https://www.rcsb.org/) and Electron Microscopy Data Bank (EMDB; https://www.ebi.ac.uk/pdbe/emdb/) under the accession codes 6VRH and 21368, 6VRK and 21369, and 6VRL and 21370, respectively. The half maps for each dataset have also been deposited in the EMDB (https://www.ebi.ac.uk/pdbe/emdb/). The x-ray coordinates for Br-paroxetine and I-paroxetine have been deposited in the PDB (https://www.rcsb.org/) under accession codes 6W2B and 6W2C, respectively.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Coleman JA</collab><collab>Navratna V</collab><collab>Yang D</collab></person-group><year iso-8601-date="2020">2020</year><source>Cryo-EM structure of the wild-type human serotonin transporter complexed with paroxetine and 8B6 Fab</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/6VRH">https://www.rcsb.org/structure/6VRH</ext-link><comment>Protein Data Bank, 6VRH</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Coleman JA</collab><collab>Navratna V</collab><collab>Yang D</collab></person-group><year iso-8601-date="2020">2020</year><source>Cryo-EM structure of the wild-type human serotonin transporter complexed with paroxetine and 8B6 Fab</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-21368">https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-21368</ext-link><comment>EMDB, 21368</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Coleman JA</collab><collab>Navratna V</collab><collab>Yang D</collab></person-group><year iso-8601-date="2020">2020</year><source>Cryo-EM structure of the wild-type human serotonin transporter complexed with Br-paroxetine and 8B6 Fab</source><ext-link ext-link-type="uri" xlink:href="rcsb.org/structure/6VRK">rcsb.org/structure/6VRK</ext-link><comment>Protein Data Bank, 6VRK</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Coleman JA</collab><collab>Navratna V</collab><collab>Yang D</collab></person-group><year iso-8601-date="2020">2020</year><source>Cryo-EM structure of the wild-type human serotonin transporter complexed with Br-paroxetine and 8B6 Fab</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-21369">https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-21369</ext-link><comment>EMDB, 21369</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Coleman JA</collab><collab>Navratna V</collab><collab>Yang D</collab></person-group><year iso-8601-date="2020">2020</year><source>Cryo-EM structure of the wild-type human serotonin transporter complexed with I-paroxetine and 8B6 Fab</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/6VRL">https://www.rcsb.org/structure/6VRL</ext-link><comment>Protein Data Bank, 6VRK</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Coleman JA</collab><collab>Navratna V</collab><collab>Yang D</collab></person-group><year iso-8601-date="2020">2020</year><source>Cryo-EM structure of the wild-type human serotonin transporter complexed with I-paroxetine and 8B6 Fab</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-21370">https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-21370</ext-link><comment>EMDB, 21370</comment></element-citation><element-citation id="dataset7" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Coleman JA</collab><collab>Navratna V</collab><collab>Yang D</collab></person-group><year iso-8601-date="2020">2020</year><source>Anomalous bromine signal reveals the position of Br-paroxetine complexed with the serotonin transporter at the central site</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/6W2B">https://www.rcsb.org/structure/6W2B</ext-link><comment>Protein Data Bank, 6W2B</comment></element-citation><element-citation id="dataset8" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Coleman JA</collab><collab>Navratna V</collab><collab>Yang D</collab></person-group><year iso-8601-date="2020">2020</year><source>Anomalous iodine signal reveals the position of I-paroxetine complexed with the serotonin transporter at the central site</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/6W2C">https://www.rcsb.org/structure/6W2C</ext-link><comment>Protein Data Bank, 6W2C</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-56427-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>